TOPIC

New Techniques and New Developments in Radiation Therapy: State of the Art

MODERATORS

Hope Rugo, MD, Professor of Medicine, Director of Breast Oncology and Clinical Trials Education, Medical Director of Cancer Infusion Services, UCSF Helen DIller Family Comprehensive Cancer Center

Laura Crocitto, MD, Vice President and Chief Medical Officer for Cancer Services, Medical Director, UCSF Helen Diller Family Comprehensive Cancer Center

-------

PRESENTATIONS

"De-escalation of Radiotherapy for Breast Cancer"

Nicolas Prionas, MD, PhD, Assistant Professor of Medicine Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center

After completing this course, attendees will have improved their skills and strategies for:

• Reviewing the literature supporting hypofractionated and ultrahypofractionated radiotherapy for early-stage breast cancer.
• Discussing de-escalation of radiotherapy in exceptional responders to neoadjuvant therapy.

-------

"Radiotherapy Approaches for CNS Metastatic Disease in Era of Targeted Therapies"

Steve Braunstein, MD, PhD, Associate Professor and Vice Chair of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center

After completing this course, attendees will have improved their skills and strategies for:

• Understanding radiotherapy treatment de-intensification for patients with central nervous system metastatic disease as part of modern interdisciplinary oncologic management.
• Describing the emerging role of radiotherapy treatment intensification in select scenarios for patients with diffuse or recurrent metastatic disease in the central nervous system.

-------

"Liver Stereotactic Body Radiotherapy (SBRT) and its Combinations with Other Local and Systemic Therapies"

Mekhail Anwar, MD, PhD, Associate Professor of Medicine Department of Radiation Oncology

After completing this course, attendees will have improved their skills and strategies for:

• Identifying the role of radiation in liver metastases.
• Describing the patient selection for SBRT for liver metastases.
• Reviewing tumor size and distribution for optimal control with SBRT.

-------

"Radiotherapy for Localized Prostate Cancer: Where we are and where we are headed"

Mack Roach lll MD, FACR, FASTRO, FASCO, Professor of Radiation Oncology and Urology, Director of Particle Therapy Research Program & Outreach, Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center

After completing this course, attendees will have improved their skills and strategies for:

• Describing the history of and recent advances in the technical aspects in the delivery of radiation in the treatment of localized prostate cancer.
• Identifying the recent advances in the use of biomarkers with prognostic and predictive value when given with radiation in the treatment of localized prostate cancer.
• Explaining common myths concerning the use of radiation in the treatment of localized prostate cancer.

-------

REGISTRATION

To secure your spot, please register in advance. 

• REGISTER WITH CME
• REGISTER WITHOUT CME